+

PL2015759T3 - Terapia skojarzona - Google Patents

Terapia skojarzona

Info

Publication number
PL2015759T3
PL2015759T3 PL07735778T PL07735778T PL2015759T3 PL 2015759 T3 PL2015759 T3 PL 2015759T3 PL 07735778 T PL07735778 T PL 07735778T PL 07735778 T PL07735778 T PL 07735778T PL 2015759 T3 PL2015759 T3 PL 2015759T3
Authority
PL
Poland
Prior art keywords
alovudine
zidovudine
administration
molar ratio
combination therapy
Prior art date
Application number
PL07735778T
Other languages
English (en)
Polish (pl)
Inventor
Hong Zhang
Bo Oberg
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of PL2015759T3 publication Critical patent/PL2015759T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31678Of metal
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31855Of addition polymer from unsaturated monomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PL07735778T 2006-05-05 2007-05-04 Terapia skojarzona PL2015759T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0608876.9A GB0608876D0 (en) 2006-05-05 2006-05-05 Combination therapy
PCT/IB2007/051688 WO2007129274A2 (fr) 2006-05-05 2007-05-04 Thérapie en combinaison
EP07735778A EP2015759B1 (fr) 2006-05-05 2007-05-04 Thérapie en combinaison

Publications (1)

Publication Number Publication Date
PL2015759T3 true PL2015759T3 (pl) 2011-01-31

Family

ID=36603961

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07735778T PL2015759T3 (pl) 2006-05-05 2007-05-04 Terapia skojarzona

Country Status (19)

Country Link
US (3) US20090170806A1 (fr)
EP (1) EP2015759B1 (fr)
JP (1) JP2009536192A (fr)
CN (1) CN101437525B (fr)
AT (1) ATE476187T1 (fr)
AU (1) AU2007246644B2 (fr)
BR (1) BRPI0710730A2 (fr)
CA (1) CA2651232C (fr)
DE (1) DE602007008226D1 (fr)
DK (1) DK2015759T3 (fr)
EA (1) EA014778B1 (fr)
ES (1) ES2349486T3 (fr)
GB (1) GB0608876D0 (fr)
HK (1) HK1132651A1 (fr)
MX (1) MX2008013491A (fr)
PL (1) PL2015759T3 (fr)
PT (1) PT2015759E (fr)
WO (1) WO2007129274A2 (fr)
ZA (1) ZA200809110B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013119193A2 (fr) * 2010-10-21 2013-08-15 Tufts University Dépistage et traitement basés sur les mitochondries extracellulaires

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
SE464168B (sv) * 1989-07-19 1991-03-18 Bo Fredrik Oeberg Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)
DE69128626T2 (de) * 1990-07-19 1998-05-20 The Wellcome Foundation Ltd., Greenford Enzyminaktivatoren
EP0470355B1 (fr) 1990-08-06 1996-06-05 American Cyanamid Company Procédé de production de déoxynucléosides
DE4026265A1 (de) * 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
EP0698032B1 (fr) 1993-05-12 1998-07-29 Rhodia Limited Preparation de fluoro-nucleosides et intermediaires pour ce faire
DE4402492A1 (de) 1994-01-28 1995-08-03 Boehringer Mannheim Gmbh Verfahren zur Herstellung von unsymmetrischen Phosphorsäurediestern
DE4418690A1 (de) 1994-05-28 1996-01-11 Boehringer Mannheim Gmbh Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel
JP2002502826A (ja) * 1998-02-09 2002-01-29 アヴェンティス ファーマシューティカルズ プロダクツ インコーポレイテッド Hiv感染の治療用組成物および方法
SE0100733D0 (sv) * 2001-03-05 2001-03-05 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
BR0311141A (pt) 2002-06-27 2005-06-07 Medivir Ab Interação sinergìstica de abacavir e alovudine
EP1610782A1 (fr) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Combinaison antivirale d'une dipyridodiazepinone et compose antiretroviral
DE602004024584D1 (de) * 2004-01-08 2010-01-21 Medivir Ab Inhibitoren der nicht-nukleotidischen reversen transkriptase

Also Published As

Publication number Publication date
PT2015759E (pt) 2010-10-28
ZA200809110B (en) 2009-08-26
WO2007129274A2 (fr) 2007-11-15
CN101437525A (zh) 2009-05-20
WO2007129274A9 (fr) 2009-03-12
DE602007008226D1 (de) 2010-09-16
CN101437525B (zh) 2011-11-23
EA200870501A1 (ru) 2009-04-28
EA014778B1 (ru) 2011-02-28
US20090170806A1 (en) 2009-07-02
HK1132651A1 (en) 2010-03-05
DK2015759T3 (da) 2010-11-15
ES2349486T3 (es) 2011-01-04
AU2007246644A1 (en) 2007-11-15
WO2007129274A3 (fr) 2008-03-06
EP2015759B1 (fr) 2010-08-04
EP2015759A2 (fr) 2009-01-21
JP2009536192A (ja) 2009-10-08
BRPI0710730A2 (pt) 2012-03-13
ATE476187T1 (de) 2010-08-15
MX2008013491A (es) 2008-10-29
US20120115807A1 (en) 2012-05-10
US20130217646A1 (en) 2013-08-22
CA2651232A1 (fr) 2007-11-15
AU2007246644B2 (en) 2010-09-30
GB0608876D0 (en) 2006-06-14
CA2651232C (fr) 2013-12-31

Similar Documents

Publication Publication Date Title
WO2015151079A3 (fr) Analogues d'auristatine et leur conjugués avec des molécules de liaison cellulaire
EP3173092A3 (fr) Composition contenant un arn pour le traitement de maladies tumorales
PH12012501003B1 (en) Oxygen linked pyrimidine derivatives
WO2016161342A3 (fr) Dérivés de nitrobenzyle d'agents anticancéreux
MX2011013176A (es) Motivos de modificación química para inhibidores y miméticos del miarn.
TW200604192A (en) Compounds and methods for inhibiting mitotic progression
MX2009012155A (es) Combinación farmacéutica sinérgica para el tratamiento de cáncer.
HN2006009702A (es) Composicion farmaceutica para el tratamiento del cancer
HK1133787A1 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
MY148948A (en) Catecholamine derivatives and prodrugs thereof
LU92203I9 (fr)
MX2023014492A (es) Compuestos utiles en la terapia para el vih.
WO2017091767A3 (fr) Formulations de médicaments pour le traitement du cancer
WO2009140675A3 (fr) Thérapie combinée comportant un alcaloïde antitumoral
MXPA06012961A (es) Ficotoxinas y usos de las mismas.
MX2019003685A (es) Composicion farmaceutica para uso en el tratamiento terapeutico del cancer y complicaciones del cancer.
WO2009138507A3 (fr) Thérapie combinée contre le cancer
PL2015759T3 (pl) Terapia skojarzona
WO2017021974A3 (fr) Nouvelle composition synergique de lécithine et lysolécithine pour améliorer la biodisponibilité et la solubilité des composés et des extraits hydrophobes
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
WO2009102375A3 (fr) Utilisation d’avicines pour l’administration d’agents thérapeutiques et diagnostiques
RS20120482A1 (en) PHARMACEUTICAL COMPOSITIONS OF VERY LOW TOXICITY CONTAINING DITERPEN COMPOUNDS WITH ANTINEOPLASTIC ACTION
IL197769A (en) The history of morphine, medicinal preparations containing them and their use in the preparation of pain medication
MX2021011610A (es) Combinaciones de iadademstat para terapia contra el cancer.
BRPI0508714A (pt) utilização de um derivado do pirazol, para a preparação a de medicamentos úteis na prevenção e no tratamento da bronquite crÈnica e da broncopneumopatia crÈnica obstrutiva
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载